If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 66   2005   NUMBER 3

Publisher Note

281 Enriching Our Heritage.
[PDF]

Original Articles

283 Tachyphylaxis in Unipolar Major Depressive Disorder. David A. Solomon, Andrew C. Leon, Timothy I. Mueller, William Coryell, Jedediah J. Teres, Michael A. Posternak, Lewis L. Judd, Jean Endicott, and Martin B. Keller
[Abstract] [PDF]

291 Weight Changes in Postpartum Women With Remitted Depression. Barbara L. Gracious, Barbara H. Hanusa, Katherine L. Wisner, Kathleen S. Peindl, and James M. Perel
[Abstract] [PDF]

294 Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis. Lenard A. Adler, Thomas J. Spencer, Denái R. Milton, Rodney J. Moore, and David Michelson
[Abstract] [PDF]

300 Schizophrenia Patients With a History of Severe Violence Differ From Nonviolent Schizophrenia Patients in Perception of Emotions but Not Cognitive Function. Henry Silver, Craig Goodman, Gabriella Knoll, Victoria Isakov, and Ilan Modai
[Abstract] [PDF]

309 Substance Use Disorders in Individuals With Body Dysmorphic Disorder. [CME] Jon E. Grant, William Menard, Maria E. Pagano, Christina Fay, and Katharine A. Phillips
[Abstract] [PDF]

317 Safety of Haloperidol and Penfluridol in Pregnancy: A Multicenter, Prospective, Controlled Study. Orna Diav-Citrin, Svetlana Shechtman, Shani Ornoy, Judy Arnon, Christof Schaefer, Hanneke Garbis, Maurizio Clementi, and Asher Ornoy
[Abstract] [PDF]

323 Extended-Release Carbamazepine Capsules as Monotherapy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Richard H. Weisler, Paul E. Keck, Jr., Alan C. Swann, Andrew J. Cutler, Terence A. Ketter, and Amir H. Kalali, for the SPD417 Study Group
[Abstract] [PDF]

331 Male Sexual Dysfunction and Quality of Life in Schizophrenia. Mark Olfson, Thomas Uttaro, William H. Carson, and Eskinder Tafesse
[Abstract] [PDF]

339 Bipolar Disorder With Comorbid Cluster B Personality Disorder Features: Impact on Suicidality. [CME] Jessica L. Garno, Joseph F. Goldberg, Paul Michael Ramirez, and Barry A. Ritzler
[Abstract] [PDF]

346 Pharmacoeconomic Analysis of Sertraline Treatment of Depression in Patients With Unstable Angina or a Recent Myocardial Infarction. Christopher M. O'Connor, Alexander H. Glassman, and David J. Harrison
[Abstract] [PDF]

353 Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder. Lorrin M. Koran, Elias Aboujaoude, Kim D. Bullock, Bettina Franz, Nona Gamel, and Michael Elliott
[Abstract] [PDF]

360 Citalopram Versus Sertraline in Late-Life Nonmajor Clinically Significant Depression: A 1-Year Follow-Up Clinical Trial. Paola Rocca, Paolo Calvarese, Fabrizio Faggiano, Livio Marchiaro, Federica Mathis, Elisa Rivoira, Barbara Taricco, and Filippo Bogetto
[Abstract] [PDF]

370 Preliminary Observations on the Effectiveness of Levetiracetam in the Open Adjunctive Treatment of Refractory Bipolar Disorder. Robert M. Post, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Susan L. McElroy, Paul E. Keck, Jr., Gabriele S. Leverich, Ralph Kupka, Willem A. Nolen, David A. Luckenbaugh, Jorg Walden, and Heinz Grunze
[Abstract] [PDF]

375 Recovery From Schizophrenic Psychoses Within the Northern Finland 1966 Birth Cohort. Erika Lauronen, Johanna Koskinen, Juha Veijola, Jouko Miettunen, Peter B. Jones, Wayne S. Fenton, and Matti Isohanni
[Abstract] [PDF]

384 The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia: A Randomized, Placebo-Controlled, Crossover Clinical Trial. Frank P. Zemlan, J. Jeffery Mulchahey, Martin B. Scharf, David W. Mayleben, Russell Rosenberg, and Alan Lankford
[Abstract] [PDF]

391 Assessing Demoralization and Depression in the Setting of Medical Disease. Lara Mangelli, Giovanni A. Fava, Silvana Grandi, Luigi Grassi, Fedra Ottolini, Piero Porcelli, Chiara Rafanelli, Marco Rigatelli, and Nicoletta Sonino
[Abstract] [PDF]

Letters To the Editor

395 Antipsychotic Medication and Diabetes Mellitus. Leslie L. Citrome · Reply by Dan Cohen and Ronald P. Stolk
[PDF]

396 Increased Efficacy With Addition of Clozapine to Aripiprazole: Alternative Explanations. John R. DeQuardo · Reply by Sabina Lim
[PDF]

396 Lithium Dosing Schedule and Renal Insufficiency. Eric G. Smith · Reply by Elie Lepkifker
[PDF]

398 Single Versus Multiple Daily Dosing of Lithium: Renal Effects. Chekkera Shammi · Reply by Elie Lepkifker
[PDF]

399 Cholesterol and Lithium Levels Were Correlated but Serum HDL and Total Cholesterol Levels Were Not Associated With Current Mood State in Bipolar Patients. Carmen Diaz-Sastre, Maria M. Perez-Rodriguez, Alberto Cebollada, Jeronimo Saiz Ruiz, Enrique Baca-Garcia, and Jose de Leon
[PDF]

400 Serious Rash With Lamotrigine After Carbamazepine Discontinuation: A Case Report. Anton A. Subuh Surja, Kathryn E. Brotzge, and Rif S. El-Mallakh
[PDF]

401 Correction. Stahl SM. Prophylactic antipsychotics: do they keep you from catching schizophrenia? (J Clin Psychiatry 2004;65:1445-1446)
[PDF]

Book Reviews 402